Accordingly, we used Ki67 as a positive control for histopathological staging in our study and compared it with our novel biomarkers, but the obvious insufficiency of Ki67 is that it cannot recognize the different histological stages of cervical cancer. The gene discussed is MKI67; the disease is cervical carcinoma.